Companies / Alto Neuroscience, Inc.
Alto Neuroscience, Inc.
NYSE: ANROCIK 1999480MOUNTAIN VIEW, CA
Financials
Ownership
39.2M shares outstanding · as of Aug 7, 2026
Ownership
| Insiders | 3.21% | 1,258,009 |
| 10%+ / strategic | 3.91% | 1,536,000 |
| Institutions | 65.91% | 25,864,775 |
| Public float | 26.97% | 10,583,320 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 8
View all →| Insider | % of shares | Shares |
|---|---|---|
Etkin AmitCEOPRESIDENT AND CEO · Director | 3.14% | 1,233,949 |
Smith Nicholas ConradCHIEF FINANCIAL OFFICER & CBO | 0.06% | 24,060 |
Cox Christopher NixonDirector | — | — |
Hanley Jr. Michael ConickCHIEF OPERATING OFFICER | — | — |
Manji HusseiniDirector | — | — |
Sanchez RamiroFormerDirector | — | — |
Savitz AdamFormerCHIEF MEDICAL OFFICER | — | — |
York GwillDirector | — | — |
Institutional holders 103
View all →| Holder | Value | % of shares |
|---|---|---|
| $66.00M | 9.45% | |
| $55.97M | 5.40% | |
| $45.18M | 5.12% | |
| $44.23M | 6.33% | |
| $32.45M | 4.65% | |
| $28.60M | 4.09% | |
| $27.34M | 3.91% | |
| $24.31M | 3.48% | |
| $19.93M | 2.85% | |
| $18.48M | 2.09% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 1, 2026 | Etkin Amit CEO | Other | Common Stock | $122.6K | -6K -0.50% | 1,233,949 3.14% of shares | low |
| Mar 1, 2026 | Smith Nicholas Conrad Executive | Other | Common Stock | $55.3K | -3K -10.44% | 24,060 0.06% of shares | low |
| Feb 11, 2026 | Smith Nicholas Conrad Executive | Grant | Employee Stock Option (Right to Buy) | — | +200K | 200,000 0.51% of shares | low |
| Feb 11, 2026 | Savitz Adam Executive | Grant | Employee Stock Option (Right to Buy) | — | +124K | 124,000 0.32% of shares | low |
| Feb 11, 2026 | Etkin Amit CEO | Grant | Employee Stock Option (Right to Buy) | — | +306K | 306,000 0.78% of shares | low |
| Jan 2, 2026 | Manji Husseini Director | Grant | Employee Stock Option (right to buy) | — | +4K | 4,228 0.01% of shares | low |
| Jan 2, 2026 | York Gwill Director | Grant | Stock Option (right to buy) | — | +5K | 5,243 0.01% of shares | low |
| Jan 2, 2026 | Cox Christopher Nixon Director | Grant | Stock Option (right to buy) | — | +7K | 7,189 0.02% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Perceptive Advisors LLC | Passive13G/A | — |
| Armistice Capital, LLC | Passive13G/A | — |
| Armistice Capital, LLC | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G/A | — |
| Commodore Capital LP | Passive13G/A | — |
| K2 HealthVentures Equity Trust LLC | Passive13G/A | — |
| Vestal Point Capital, LP | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| ANRO | Common Stock | 02157Q109 |